Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT LLC | 02-14-2024 | 12-31-2023 | 67 | 335,961,131 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| SPRD S&P Biotech ETF | LONG OPTION CALLS | Liquidated | $0 | 0 | 0.01 | 300,000 | +Inf | 12-31-2023 | |
| ImmunoGen Inc | EQUITIES | Liquidated | $0 | 0 | 0.01 | 0.01 | -112,565 | -7.93 | 12-31-2023 |
| Merus NV | EQUITIES | 3 | $17,753,478 | 645,581 | 0.01 | 0.00 | 145,581 | 29.12 | 12-31-2023 |
| Mersana Therapeutics Inc | EQUITIES | 4 | $14,894,716 | 6,420,136 | 0.00 | 0.00 | 1,420,136 | 28.40 | 12-31-2023 |
